These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12733497)

  • 21. [Exposure to lead in the general environment and in places of employment. II. Physiopathological and clinical aspects].
    Cavatorta A; Guariglia A; Minari M; Neri TM; Perinotto P; Franchini I
    G Clin Med; 1974 Feb; 55(2):100-30. PubMed ID: 4371438
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuropathy: nutritional prevention/treatment suggested.
    James JS
    AIDS Treat News; 1999 Mar; (No 314):7-8. PubMed ID: 11366243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic complications of HIV therapy.
    Chow DC; Day LJ; Souza SA; Shikuma CM
    IAPAC Mon; 2006 Sep; 12(9):302-17. PubMed ID: 17378067
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathogenesis and treatment of lipodystrophy: what clinicians need to know.
    Sattler FR
    Top HIV Med; 2008; 16(4):127-33. PubMed ID: 18838747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipodystrophy syndrome. Therapeutic progress is still pending].
    Weber K; Heiken H; Stoll M; Schmidt RE; Behrens G
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():28-32. PubMed ID: 15011581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleoside analogues toxicities related to mitochondrial dysfunction: focus on HIV-infected children.
    Viganò A; Giacomet V
    Antivir Ther; 2005; 10 Suppl 2():M53-64. PubMed ID: 16152706
    [No Abstract]   [Full Text] [Related]  

  • 27. Overcoming peripheral neuropathy.
    Boucaud-Obali D
    Body Posit; 2002; 15(4):27-9. PubMed ID: 12400478
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV or HIV-therapy? Causal attributions of symptoms and their impact on treatment decisions among women and men with HIV.
    Kremer H; Sonnenberg-Schwan U; Arendt G; Brockmeyer NH; Potthoff A; Ulmer A; Graefe K; Lorenzen T; Starke W; Walker UA;
    Eur J Med Res; 2009 Apr; 14(4):139-46. PubMed ID: 19380286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
    Rabing Christensen E; Stegger M; Jensen-Fangel S; Laursen AL; Ostergaard L
    Clin Infect Dis; 2004 Nov; 39(9):1371-9. PubMed ID: 15494915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy.
    Falutz J
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):651-61. PubMed ID: 17710086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid may help neuropathy.
    AIDS Patient Care STDS; 2000 Aug; 14(8):454. PubMed ID: 10981319
    [No Abstract]   [Full Text] [Related]  

  • 32. Host factors may be more important than choice of antiretrovirals in the development of lipoatrophy.
    McComsey G; Maa JF
    AIDS Read; 2003 Nov; 13(11):539-42, 559. PubMed ID: 14649623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simply stated: feelings, whoa-oh-oh feelings...
    Res Initiat Treat Action; 1998 Jun; 4(3):19. PubMed ID: 11365537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.
    Mallewa JE; Wilkins E; Vilar J; Mallewa M; Doran D; Back D; Pirmohamed M
    J Antimicrob Chemother; 2008 Oct; 62(4):648-60. PubMed ID: 18565973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disorders of body fat distribution in HIV-1-infected patients.
    Moreno S; Miralles C; Negredo E; Domingo P; Estrada V; Gutiérrez F; Lozano F; Martínez E
    AIDS Rev; 2009; 11(3):126-34. PubMed ID: 19654854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The patient's perspective on life with antiretroviral treatment: results of an 887-person survey.
    Bertholon DR; Rossert H; Korsia S
    AIDS Read; 1999 Oct; 9(7):462-9. PubMed ID: 12737138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.
    Negredo E; Paredes R; Bonjoch A; Tuldrà A; Fumaz CR; Gel S; Garcés B; Johnston S; Arnó A; Balagué M; Jou A; Tural C; Sirera G; Romeu J; Cruz L; Francia E; Domingo P; Arrizabalaga J; Ruiz I; Arribas JR; Ruiz L; Clotet B
    Antivir Ther; 1999; 4 Suppl 3():23-8. PubMed ID: 16021868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buffalo hump in HIV patients: surgical management with liposuction.
    Sharma D; Bitterly TJ
    J Plast Reconstr Aesthet Surg; 2009 Jul; 62(7):946-9. PubMed ID: 18468504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
    Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
    J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of lipoatrophy after a four-year long interruption of antiretroviral therapy for HIV1 infection: case report.
    Parruti G; Toro GM
    BMC Infect Dis; 2005 Oct; 5():80. PubMed ID: 16202141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.